Rescue treatment with eltrombopag in refractory cytopenias after allogeneic stem cell transplantation

Background: Patients with post-transplant cytopenias due to poor graft function or primary engraftment failure show poor prognosis with a high mortality rate mainly because of graft versus host disease (GVHD), infection and/or bleeding. Treatment options are scarce and a CD34+ stem cell boost or a s...

Full description

Bibliographic Details
Main Authors: Semra Aydin, Chiara Dellacasa, Sara Manetta, Luisa Giaccone, Laura Godio, Giorgia Iovino, Benedetto Bruno, Alessandro Busca
Format: Article
Language:English
Published: SAGE Publishing 2020-10-01
Series:Therapeutic Advances in Hematology
Online Access:https://doi.org/10.1177/2040620720961910